Progressive atrophy of the retina, choriocapillaries and choroid (the back layers of the eye). This tends to lead to progressive night blindness and visual field constriction.
Genetics
BCD is inherited in an autosomal recessive manner.[2] This means the defective gene responsible for the disorder is located on an autosome, and two copies of the defective gene (one inherited from each parent) are required in order to be born with the disorder. The parents of an individual with an autosomal recessive disorder both carry one copy of the defective gene, but usually do not experience any signs or symptoms of the disorder.
BCD is associated with mutations in the CYP4V2 gene.[2]
The nematode C. elegans has a duplicated gene (cyp31A2 and cyp31A3) that are orthologous of the human gene.
These genes code for cytochrome P450s involved in fatty acid synthesis.[7]
Diagnosis
This section is empty. You can help by adding to it. (September 2017)
Treatment
At this time, there is no treatment for BCD. Genetic studies are being conducted to find treatments for patients with BCD.[8]
^Bietti G (1937). "Ueber familiaeres Vorkommen von 'Retinitis punctata albescens' (verbunden mit 'Dystrophia marginalis cristallinea corneae'), Glitzern des Glaskoerpers und anderen degenerativen Augenveraenderungen". Klinische Monatsblätter für Augenheilkunde. 99: 737–757.